Ex-Mod­er­na com­mer­cial leader lands at Cel­sion as CEO; Schwan song: Chang­ing of the guard at Roche to take ef­fect next year

Less than 12 months in­to her job lead­ing the com­mer­cial roll­out of one of the world’s biggest-sell­ing biotech prod­ucts, Mod­er­na’s Covid-19 vac­cine, Corinne Le Goff de­part­ed the house­hold name in De­cem­ber 2021, but her fu­ture in the in­dus­try is just now com­ing in­to clear view.

The more than 30-year in­dus­try vet­er­an — whose posts have run the gamut across Pfiz­er, Sanofi, Mer­ck, Roche and Am­gen — is now CEO and pres­i­dent of Cel­sion, which it­self is po­ten­tial­ly look­ing to get in­to the SARS-CoV-2 vac­cine land­scape, al­beit way lat­er than her pre­vi­ous em­ploy­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER